Bong-Yong Lee

Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea.

ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX.

Kyung Hee University provides academic courses and grants academic degrees. It has udergraduate, graduate, international student, and international faculty programs. The firm also provides scholarships and operates Kyung Hee Medical Center, Kyung Hee University Hospital at Gangdong, and Kangnam Korean Hospital. The company was founded on February 15, 1949 and is headquartered in Seoul, South Korea.

SK Chemicals Co. Ltd. engages in the manufacture of chemicals and develops synthetic and natural drugs. It operates through the following business divisions: Green Chemicals and Life Science. The Green Chemicals division offers high performance polyethylene terephthalate glycol resins, polyester binders, water treatment chemicals, coolant and antifreeze, chemicals for housing, industrial biocide, polyethylene terephthalate resins, carbon fiber composite, acoustic absorption materials and acoustic thermal insulation and biodiesel. The Life Science division provides musculoskeletal, gastrointestinal, cardiovascular, urology, antibiotics, blood preparations, vaccines, parenteral nutrition and other prescription (Rx). The company was founded on July 1, 1969 and is headquartered in Seongnam, South Korea.